Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h

BACKGROUND: The efficacy and safety of intravenous alteplase administered 3–4.5 h after acute ischemic stroke have been demonstrated. However, whether responses differ between low-dose and standard-dose alteplase during this time window and whether certain subgroups benefit more remain unknown. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chih-Hao, Tang, Sung-Chun, Chen, Yu-Wei, Chen, Chih-Hung, Tsai, Li-Kai, Sung, Sheng-Feng, Lin, Huey-Juan, Huang, Hung-Yu, Po, Helen L., Sun, Yu, Chen, Po-Lin, Chan, Lung, Wei, Cheng-Yu, Lee, Jiunn-Tay, Hsieh, Cheng-Yang, Lin, Yung-Yang, Lien, Li-Ming, Jeng, Jiann-Shing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883875/
https://www.ncbi.nlm.nih.gov/pubmed/35237225
http://dx.doi.org/10.3389/fneur.2022.763963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883875/
https://www.ncbi.nlm.nih.gov/pubmed/35237225
http://dx.doi.org/10.3389/fneur.2022.763963

Ejemplares similares